Published in Onco Targets Ther on August 30, 2016
Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells. Cancers (Basel) (2017) 0.78
Long non-coding RNAs: a rising biotarget in colorectal cancer. Oncotarget (2017) 0.75
Comprehensive investigation of a novel differentially expressed lncRNA expression profile signature to assess the survival of patients with colorectal adenocarcinoma. Oncotarget (2017) 0.75
Long non-coding RNA CCAT2 is associated with poor prognosis in hepatocellular carcinoma and promotes tumor metastasis by regulating Snail2-mediated epithelial-mesenchymal transition. Onco Targets Ther (2017) 0.75
Up-regulation of long non-coding RNA SPRY4-IT1 promotes tumor cell migration and invasion in lung adenocarcinoma. Oncotarget (2017) 0.75
The prognostic value of abnormally expressed lncRNAs in colorectal cancer: A meta-analysis. PLoS One (2017) 0.75
Integrated analysis of competing endogenous RNA network revealing lncRNAs as potential prognostic biomarkers in human lung squamous cell carcinoma. Oncotarget (2017) 0.75
Global cancer statistics. CA Cancer J Clin (2011) 185.92
Epithelial-mesenchymal transitions in development and disease. Cell (2009) 39.17
Evolution and functions of long noncoding RNAs. Cell (2009) 17.54
Cancer statistics in China, 2015. CA Cancer J Clin (2016) 12.92
The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol (2012) 5.60
Colorectal cancer screening: scientific review. JAMA (2003) 4.96
The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer Res (2011) 2.52
Long noncoding RNA SPRY4-IT1 is upregulated in esophageal squamous cell carcinoma and associated with poor prognosis. Tumour Biol (2014) 1.46
High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinoma. Int J Clin Exp Pathol (2014) 1.37
EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition. Cell Death Dis (2014) 1.34
Long noncoding RNA H19 indicates a poor prognosis of colorectal cancer and promotes tumor growth by recruiting and binding to eIF4A3. Oncotarget (2016) 1.20
Long noncoding RNAs in mammalian cells: what, where, and why? Wiley Interdiscip Rev RNA (2010) 1.19
Up-regulation of 91H promotes tumor metastasis and predicts poor prognosis for patients with colorectal cancer. PLoS One (2014) 1.08
Decreased long noncoding RNA SPRY4-IT1 contributing to gastric cancer cell metastasis partly via affecting epithelial-mesenchymal transition. J Transl Med (2015) 0.99
Long noncoding RNA SPRY4-IT1 predicts poor patient prognosis and promotes tumorigenesis in gastric cancer. Tumour Biol (2015) 0.99
Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer. Prostate Cancer Prostatic Dis (2015) 0.97
Nomograms for predicting prognostic value of inflammatory biomarkers in colorectal cancer patients after radical resection. Int J Cancer (2016) 0.96
The plasma lncRNA acting as fingerprint in non-small-cell lung cancer. Tumour Biol (2015) 0.94
Upregulation of long non-coding RNA TUG1 correlates with poor prognosis and disease status in osteosarcoma. Tumour Biol (2015) 0.94
Prognostic value of long non-coding RNA HOTAIR in various cancers. PLoS One (2014) 0.92
Circular RNAs as a new field in gene regulation and their implications in translational research. Epigenomics (2016) 0.78
Long noncoding RNA, tissue differentiation-inducing nonprotein coding RNA is upregulated and promotes development of esophageal squamous cell carcinoma. Dis Esophagus (2016) 0.78